MiniMed - MNMD- Profile

Minimed Inc. The principal activities of the Group are the design, development, manufacture and sale of advanced microinfusion systems and continuous glucose monitoring systems for the intensive management of diabetes; drug delivery expertise to develop infusion devices for the treatment of other chronic medical conditions; sale of external insulin pumps and related supplies; and provider of insulin systems. The Group operates in North America, Europe and Australia. External infusion pumps accounted for 54% of 2000 revenues; diabetes related disposal products, 40%; other diabetes supplies, 4%, glucose monitoring systems, 1%; pharmaceutical products; 15% and implantable pumps, nominal. Infusion pumps acctd for 54% of 2000 revs; Disposables, 40%; Supplies, 4%; Glucose sys, 1%; Pharmaceuticals, 1% & Pumps, nom